Status:
ACTIVE_NOT_RECRUITING
The ILERVAS Project: Assessing the Prevalence of Subclinical Vascular Disease and Hidden Kidney Disease
Lead Sponsor:
Institut de Recerca Biomèdica de Lleida
Collaborating Sponsors:
Diputació de Lleida
Jaume Arnó Renal Foundation
Conditions:
Atherosclerosis
Chronic Kidney Diseases
Eligibility:
All Genders
45-70 years
Phase:
NA
Brief Summary
BACKGROUND AND OBJECTIVES: Cardiovascular disease is the leading cause of death despite huge primary and secondary prevention policies with a strong economic burden. The primary objectives of the ILE...
Detailed Description
STUDY DESIGN AND POPULATION: Randomized interventional study. From 2015 to 2018, 16,660 participants (8,330 in the intervention group (Mobile Unit Follow-up Group) and 8,330 in the no intervention gr...
Eligibility Criteria
Inclusion
- women (50-70 years) and men ( 45-65 years) with at least one cardiovascular risk factor (hypertension, dyslipidemia, obesity (BMI \>30 Kg/m2), current smoking habit or former smoker (\<10 years), first-degree family history of early cardiovascular disease).
Exclusion
- Prior medical history of cardiovascular disease.
- Diabetes.
- Glomerular filtration rate (CKD-EPI \< 60 ml/min/1.73m2).
- Active neoplasm or acute disease.
- A life expectancy \< 18 months.
- Pregnancy.
Key Trial Info
Start Date :
January 15 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2028
Estimated Enrollment :
16660 Patients enrolled
Trial Details
Trial ID
NCT03228459
Start Date
January 15 2015
End Date
December 31 2028
Last Update
March 6 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Fundació Renal Jaume Arnò
Lleida, Spain, 25006
2
Primary Care centre
Lleida, Spain, 25007
3
Institut de recerca Biomèdica de Lleida
Lleida, Spain, 25198